JPI InvestFranΓ§ais
JPI AI Analyst AI assistant Β· JPI Invest
Answers based on the tool's data Β· not financial advice Β· full analysis (free)
All stocks β€Ί Health Care β€Ί MCK

Are analysts right about McKesson Corporation (MCK)?

Health Care Β· price $891 Β· median target $1,000 (+12%)
In short β€” Over the past 12 months, 72% of analyst price targets on McKesson Corporation turned out profitable, for an average return of +23% (across 159 timestamped calls). The current consensus is "Buy" with a median price target of $1,000 (+12% vs the current $891, from 9 analysts).

πŸ“ˆ See the interactive version (live chart) β†’

πŸ”— Related pages on McKesson Corporation β€” Financials & fundamentals  Β·  If I had invested  Β·  Dividend
Current price
$891
Median target (12 mo)
$1,000 +12%
Analyst accuracy (1 yr)
72%
Avg return / call (1 yr)
+23%
πŸ’° Performance & Β« if I invested Β» πŸ“Š Interactive analysis

Historical analyst accuracy

For McKesson Corporation, we replayed every analyst price target of the past 12 months and measured the real outcome: 72% were profitable, average return +23% (159 calls). At 3 months: +4% average return (51% profitable). The higher the %, the more often analysts were right on this stock.

Most reliable analysts on this stock (past track record)

Their past track record on this stock (targets replayed against real prices) β€” not a forecast of what will happen.

Analyst / brokerCalls i% profitable iAvg return i
Morgan Stanley2979%+30%
Barclays1354%+14%
Baird1283%+25%
UBS1191%+31%
Citigroup1090%+32%

Valuation

Is McKesson Corporation overvalued, and is it a good time to buy McKesson Corporation right now? If you're wondering, here's a recap to make up your own mind: McKesson Corporation's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.

The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β€” but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.

MetricMcKesson CorporationSector median (Health Care)
P/E24.029.4
Forward P/E17.617.1
Net margin1%12%

πŸ‘‰ McKesson Corporation trades below its sector median (24.0 vs 29.4) β€” potentially undervalued, or lower expected growth.

πŸ“– P/E, PEG, margin…: see the glossary

πŸ’΅ Dividend : McKesson Corporation pays about $3.28/share/yr β†’ 0.43% yield. what is this?

Frequently asked questions

Is McKesson Corporation a buy right now?

The analyst consensus on McKesson Corporation (MCK) is "Buy" (33 bullish, 0 bearish calls over 12 months). This is not advice: historically, 72% of their targets on this stock turned out profitable over 1 year.

What is McKesson Corporation's price target?

The median 12-month price target is $1,000 (+12% vs $891), ranging from $845 to $1,080 (9 analysts).

Are analysts accurate on McKesson Corporation?

Over 1 year, 72% of analyst targets on McKesson Corporation were profitable, for an average return of +23% (across 159 timestamped calls). This is JPI Invest's accuracy metric.

What is the McKesson Corporation stock forecast?

Analysts target a median of $1,000 within 12 months, i.e. +12% vs the current price. The most bullish targets $1,080, the most cautious $845.

What is the McKesson Corporation stock forecast for 2026 or long term (2030)?

Note: analyst targets are 12-month (median $1,000, +12%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (72%), and the stock's past trajectory.

Is McKesson Corporation overvalued?

Its P/E is 24.0, forward P/E 17.6. A forward P/E lower than the current P/E means earnings are expected to grow.

πŸ“Š See the full interactive analysis of McKesson Corporation β†’

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β€” on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free β†’ How it works: the method β†’

⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.